Chemistry:PF-06260414
From HandWiki
Short description: Chemical compound
 | |
| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C14H14N4O2S |
| Molar mass | 302.35 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
PF-06260414 is a drug which acts as a selective androgen receptor modulator (SARM), and was developed for androgen replacement therapy.[1][2][3]
See also
- AC-262536
- ACP-105
- Enobosarm
- JNJ-28330835
- Ligandrol
References
- ↑ "Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects". Clinical Therapeutics 38 (6): 1401–1416. June 2016. doi:10.1016/j.clinthera.2016.03.025. PMID 27085586.
- ↑ "Development of a multi-residue high-throughput UHPLC-MS/MS method for routine monitoring of SARM compounds in equine and bovine blood". Drug Testing and Analysis 12 (9): 1373–1379. September 2020. doi:10.1002/dta.2875. PMID 32519780. https://pure.qub.ac.uk/en/publications/b90a4809-b069-4dbd-8b3e-0c094324f563.
- ↑ "Identification of equine in vitro metabolites of seven non-steroidal selective androgen receptor modulators for doping control purposes". Drug Testing and Analysis 14 (2): 349–370. October 2021. doi:10.1002/dta.3189. PMID 34714606. https://biblio.ugent.be/publication/8740373/file/8740375.
 |  |
